OCT 16, 2018 08:22 PM PDT

Immunotherapeutic Targets A Blood-Clotting Protein

WRITTEN BY: Nouran Amin

Fibrin is a blood protein that normally does not cross to the brain, however, several neurological disorders have a defect in the blood-brain barrier that allow large molecules, like fibrin, to pass through triggering inflammation. Many studies have pointed to a leaky blood-brain barrier as an early event in brain diseases that causes neurodegeneration. The process is believed to be implicated in the death of nerve cells seen in multiple sclerosis, Alzheimer's disease, and other disorders.

Treatments intended to inhibit the blood from harming the brain have not been available due to researchers fear of targeting the blood-clotting protein, fibrin, and the effect it may hold on bleeding patients. But, now, researchers from the Gladstone Institutes have found a way to overcome this hurdle with a new immunotherapy; a highly effective antibody that inhibits the biochemical activity of fibrin that contributes to neurodegeneration in the brain

"We have developed a monoclonal antibody to target a major culprit in the blood that damages the brain," said Katerina Akassoglou, PhD, lead investigator and a professor in the Department of Neurology at UC San Francisco. "Fibrin-targeting immunotherapy could protect the brain from the toxic effects of blood leakage and may also have beneficial effects in other organs affected by inflammatory conditions with vascular damage."

In a mouse model, the new antibody would enter the brain and accumulate in fibrin-rich regions, protecting against neuro-inflammation and neurodegeneration in both disease models. The research team published their findings in Nature Immunology. "We discovered that fibrin also contributes to brain disease through oxidative stress -- an unanticipated result," says research scientist and first author of the study, Jae Kyu Ryu, PhD. "Treatment with the antibody put a damper on this fibrin-driven oxidative mechanism, which may contribute to many different neurodegenerative diseases."

Chemical Structure of Fibrin. Image via NIH

The study treated mouse models of Alzheimer’s with the antibody after they had developed an accumulation of amyloid proteins in their brain; a hallmark of the disease. In comparison, to the placebo, the mice had less brain inflammation and less neuronal death. "Our study supports that vascular damage leading to immune-driven neurodegeneration may be a common thread between diseases of different etiologies with blood-brain barrier leaks," said Akassoglou. "Targeting fibrin with immunotherapy is a new approach that could be used to test the therapeutic benefits of suppressing this pathogenic mechanism in multiple disease contexts."

Source: Gladstone Institute

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 06, 2018
Cell & Molecular Biology
JUL 06, 2018
Small Molecules Found to Dial Down Autoimmunity
Scientists have now identified two combinations of small molecules that tamp down a protein called STING....
JUL 17, 2018
Drug Discovery
JUL 17, 2018
First Drug for Smallpox Treatment
TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox, was just approved by the U.S. Food and Drug Administration to SIGA Techno...
JUL 24, 2018
Drug Discovery
JUL 24, 2018
The Chili Pepper Drug Aims To Combat Obesity
A new drug was recently developed based on capsaicin, the compound found in chili peppers that is responsible for their spicy properties, was seen to cause...
AUG 27, 2018
Cardiology
AUG 27, 2018
Drug Reduces Deaths and Hospitalization from Heart Failure
New drug reduces deaths and hospitalization rates, while also improving quality of life, for patients with rare type of cardiomyopathy....
OCT 09, 2018
Drug Discovery
OCT 09, 2018
'Copper Antibiotic Peptide' Effective in Eradicating Tuberculosis
The bacterium responsible for Tuberculosis has found a way to avoid antibiotics by hiding inside the macrophages which are the specific immune cells that a...
NOV 10, 2018
Genetics & Genomics
NOV 10, 2018
Scientists Engineer a Better Way to Direct Evolution
Directed evolution is a Nobel-prize winning technique that has now been simplified and accelerated....
Loading Comments...